Transcranial Magnetic Stimulation + Language Therapy to Treat Subacute Aphasia
Recruiting
Phase 2
Interventional Study
Stroke
Aphasia
Aphasia Following Cerebral Infarction
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 63 (estimated)
- Sponsor
- University of Pennsylvania · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to determine if Transcranial Magnetic Stimulation (TMS) combined with modified Constraint Induced Language Therapy (mCILT) is an effective treatment for aphasia when delivered in the subacute stage after stroke.
The main questions this study aims to answer are:
1. Can TMS combined with mCILT improve overall speech?
2. Can we identify specific behavioral and bio…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Left hemisphere stroke resulting in aphasia
* The stroke must have occurred between 2 and 6 weeks prior to enrollment
* Must be able to understand the nature of the study, and give informed consent
* English proficiency
* Right-handed
Exclusion Criteria:
* History of serious…
Contacts